AMPK is involved in cholestatic liver injury with bile acid dysregulation.
CDCA and UDCA inhibit the phosphorylation of AMPK and alleviate estrogen-induced cholestasis.
PKA activation contributes to the CDCA- and UDCA-induced protective effects.
FXR up-regulation may be critical for improvement of cholestasis.